Influencing Factors of Lung Shunt Fraction in Transarterial Radioembolization Treatment
Authors:
Preprint
- 3 July 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose We aimed to evaluate the influencing factors of lung shunt fraction(LSF) in patients who underwent transarterial radioembolization treatment. Methods We enrolled 105 patients who had either primary or metastatic liver disease. Planar and SPECT/CT images were obtained after intraarterial injection of 99mTc-MAA to measure LSF. Planar-based LSFs(LSFplanar), calculated as the arythmetic mean(LSFAM) and geometric mean(LSFGM), were compared to LSFSPECT/CT. Subgroup analyses were conducted to assess the impact of scattering and spillover effects in patients with target lesions located near lung. Both lungs were segmented into lower, middle and upper sections(RL,RM,RU,LL,LM,LU). For control group, ten patients with normal lung perfusion scintigraphy were included. Results The mean of LSFSPECT/CT was significantly lower than the mean of LSFGM(6.5 ± 4.1 vs 13.9 ± 8.4, p = < 0.001) and the mean of LSFAM(13.5 ± 8.4%, p = < 0.001). LSFplanar methods overestimated LSF compared to LSFSPECT/CT. LSFGM divided by 2.3 can provide more accurate estimated LSF similar to LSFSPECT/CT. In subgroup analyses, we found that mean values of RL/RU, RM/RU, LL/LU and LM/LU were 9.3 ± 7.4, 2.2 ± 1.2; 1.2 ± 0.4, and 1.2 ± 0.2, respectively. In control group, mean values of RL/RU, RM/RU, LL/LU and LM/LU were within a range of 0.9–1.1. Conclusion LSFSPECT/CT with attenuation correction can provide more accurate results compared to LSFplanar before TARE treatment. In patients who had liver lesions located adjacent to lung, the possible miscalculation of LSFSPECT/CT from scattering and spillover effect could be eliminated by exclusion of 3 cm diameter from inferior border of the right lung.Keywords
All Related Versions
This publication has 17 references indexed in Scilit:
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialThe Lancet Gastroenterology & Hepatology, 2021
- Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?CardioVascular and Interventional Radiology, 2020
- Calculation of lung mean dose and quantification of error for 90Y‐microsphere radioembolization using 99mTc‐MAA SPECT/CT and diagnostic chest CTMedical Physics, 2019
- Radioembolization lung shunt estimation based on a 90Y pretreatment procedure: A phantom studyMedical Physics, 2018
- The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient studyEJNMMI Research, 2018
- Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein ThrombosisCancer Biotherapy and Radiopharmaceuticals, 2015
- Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolizationEJNMMI Research, 2014
- Lung Dose Calculation With SPECT/CT for 90Yittrium Radioembolization of Liver CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Incidence of Radiation Pneumonitis After Hepatic Intra-Arterial Radiotherapy With Yttrium-90 Microspheres Assuming Uniform Lung DistributionAmerican Journal of Clinical Oncology, 2008
- Accuracy of the Quantification of Organ Activity from Planar Gamma Camera ImagesCancer Biotherapy and Radiopharmaceuticals, 2003